Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Targeting specific GABA-A receptor subunits shows potential in treating chronic pain

Jan. 21, 2008

Hydrogen peroxide scavenging prolongs life span in experimental Friedreich's ataxia

Jan. 21, 2008

XenoPort and GSK report top-line results for XP-13512 in the treatment of RLS

Jan. 18, 2008

EPIX reports revised results from its phase IIa clinical trial of PRX-03140 in AD

Jan. 18, 2008

Schering-Plough files NDA for sugammadex in Japan

Jan. 18, 2008

Novel treatment for spinal cord disorders reported in recent Sia Peptides patent

Jan. 18, 2008

Cerimon initiates phase II/III trials of once-daily diclofenac sodium patch for pain

Jan. 18, 2008

MAP completes SPA with FDA for phase III clinical trial of MAP-0004 for migraine

Jan. 18, 2008

Neuroprotective effects of phosphorylated PRAS40 after spinal cord injury

Jan. 18, 2008

Recent patents describe novel analgesic agents

Jan. 17, 2008

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026